Original Development Brief – Grants FDA approval to the 23andMe Personal Genome Service (PGS) test as a Class II medical device for ten diseases and conditions and outlines special controls to mitigate risks involved.
Original Development Brief – Prohibits the Central Intelligence Agency from using unmanned aerial vehicles to carry out weapons strikes or other deliberately lethal action and transfers the authority to conduct such strikes or lethal actions to the Department of Defense.
Original Development Brief – Promotes and facilitates stem cell research showing evidence of substantial clinical benefit to patients, while placing restrictions on the creation, injury, and destruction of embryos for such research.
Updated lastJune 25, 2018
for the 06/15/2017 version of HR 2918 and the 05/24/2018 version of S 2956.
Original Development Brief – Establishes a grant program for workers displaced by automation and creates an Innovation Corps that allows recent college graduates to volunteer in a job-training program for workers displaced by automation.